Jeremy Sugarman MD
Professor, Medicine, Johns Hopkins University School of Medicine
Join to View Full Profile
1809 Ashland AveRoom 203Baltimore, MD 21205
Phone+1 410-614-5634
Fax+1 410-614-5360
Dr. Sugarman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Internal Medicine, 1986 - 1989
Duke University School of MedicineClass of 1986
Certifications & Licensure
MD State Medical License 1990 - 2025
NC State Medical License 1987 - 2004
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Elected Member Institute of Medicine, 2010
- Elected Member The American Society for Clinical Investigation, 2006
Publications & Presentations
PubMed
- Clinician perspectives on disclosing public health uses of HIV antiretroviral resistance testing results.Juli Bollinger, Gail Geller, Sanjay R Mehta, Susan J Little, Jeremy Sugarman
Journal of Acquired Immune Deficiency Syndromes. 2025-06-12 - 1 citationsWhat does "appropriate scientific justification" mean for the review of human pluripotent stem cell, embryo, and related research?Erica C Jonlin, Misao Fujita, Rosario Isasi, Kazuto Kato, Megan Munsie
Stem Cell Reports. 2025-05-13 - Accurately Understanding the Potential Benefits of Decentralized Clinical Trials.Jeremy Sugarman, Effy Vayena
The American Journal of Bioethics. 2025-05-01
Journal Articles
- Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in Low-Risk HIV-Uninfected Individuals: HPTN 077, a Phase 2a Randomized Controlled TrialSusan H Eshleman, Joseph J Eron, Raphael J Landovitz, Myron S Cohen, Jeremy Sugarman, Mark A Marzinke, Craig W Hendrix, PLoS One
- Regional Differences Between People Who Inject Drugs in an HIV Prevention Trial Integrating Treatment and Prevention (HPTN 074): A Baseline AnalysisJeremy Sugarman, Susan H Eshleman, Journal of the International AIDS Society
- Perceptions of HIV Cure Research Among People Living with HIV in AustraliaJoseph D. Tucker, Jeremy Sugarman, J Sugarman, PLoS One
Press Mentions
Summaries of Health Policy Coverage from Major News OrganizationsJune 24th, 2020
A Professional Standard for Informed Consent for Stem Cell TherapiesAugust 12th, 2019- Realizing Shared Decision-Making in PracticeJuly 25th, 2019
- Join now to see all
Grant Support
- Strengthening the Master of Health Research Ethics Training ProgramUNIVERSITY OF MALAYA2018–2028
- Strengthening the Master of Health Research Ethics Training ProgramUNIVERSITY OF MALAYA2018–2028
- Risks, Benefits, and Stakeholder Perspectives of Molecular Epidemiology for HIV Prevention (HIV-ME)UNIVERSITY OF CALIFORNIA, SAN DIEGO2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
